Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-Fluorouracil Plus Alpha Interferon for Advanced Metastatic Carcinoid
NCT00002470Phase 2Completed
- Sponsor
- Mid-Atlantic Oncology Program
- Start
- Sep 1990
- Modality
- Cytokines & Interferons, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of interferon alfa and fluorouracil in Carcinoid Tumor (CT), sponsored by Mid-Atlantic Oncology Program. Primary endpoints: Objective Response Rate and Duration of Remission. Started Sep 1990; status: completed.
02
Drugs
interferon alfafluorouracil
03
Conditions
Carcinoid Tumor (CT)
Beyond the preview
Go deeper on NCT00002470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002470.